IL-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients

N. Acet Öztürk (Bursa, Turkey), A. Ursavas (Bursa, Turkey), A. Görek Dilektasli (Bursa, Turkey), E. Demirdögen (Bursa, Turkey), F. Coskun (Bursa, Turkey), D. Ediger (Bursa, Turkey), E. Uzaslan (Bursa, Turkey), D. Yöyen-Ermis (Bursa, Turkey), M. Karaca (Bursa, Turkey), O. Terzi (Bursa, Turkey), M. Bayram (Bursa, Turkey), D. Ömer (Bursa, Turkey), B. Yigitliler (Bursa, Turkey), A. Yurttas (Bursa, Turkey), S. Maharramov (Bursa, Turkey), G. Çelik (Bursa, Turkey), B. Oral (Bursa, Turkey), M. Karadag (Bursa, Turkey)

Source: Virtual Congress 2021 – COVID - 19: lessons learned
Session: COVID - 19: lessons learned
Session type: E-poster
Number: 513

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Acet Öztürk (Bursa, Turkey), A. Ursavas (Bursa, Turkey), A. Görek Dilektasli (Bursa, Turkey), E. Demirdögen (Bursa, Turkey), F. Coskun (Bursa, Turkey), D. Ediger (Bursa, Turkey), E. Uzaslan (Bursa, Turkey), D. Yöyen-Ermis (Bursa, Turkey), M. Karaca (Bursa, Turkey), O. Terzi (Bursa, Turkey), M. Bayram (Bursa, Turkey), D. Ömer (Bursa, Turkey), B. Yigitliler (Bursa, Turkey), A. Yurttas (Bursa, Turkey), S. Maharramov (Bursa, Turkey), G. Çelik (Bursa, Turkey), B. Oral (Bursa, Turkey), M. Karadag (Bursa, Turkey). IL-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients. 513

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018

Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


PP305 – Can Hematological Ratios Predict Outcome of COVID-19 Patients? Egyptian Multicentric Study
Source: ERS Lung Science Conference 2021
Year: 2021

Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Predictors of Progression in Patients with Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


Clinical Utility of Different Methods In Diagnosis Of Pulmonary Cryptococosis In Patients Without HIV Infection
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017


Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Genetic Profiles of Clinical Features in Sarcoidosis
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018

Higher Age Puts Lung-Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019

Non Invasive Ventilation in Acute Respiratory Failure in Patients of Post Tubercular Bronchiectasis: Effectiveness and Predictors of Failure.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017

Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


CT Features and Short-term Prognosis of COVID-19 Pneumonia
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021


Effects of Infliximab on FDG Uptake and Small Fiber Neuropathy Symptoms in Sarcoidosis Patients
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021



Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Assessing an Educational Intervention to Improve Recognition of Frailty in Hospitalized Patients with COPD
Source: International Congress 2019 – Medical education
Year: 2019